Methods of treating central nervous system disorders with a...

Details Methods of treating central nervous system disorders with a... Methods of treating central nervous system disorders with a...

2006-10-16

2009-08-04

Kim, Jennifer Myong M (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S563000

Reexamination Certificate

active

07569605

ABSTRACT:
The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.

REFERENCES:
patent: 3819706 (1974-06-01), Mehta et al.
patent: 3885046 (1975-05-01), Mehta
patent: 4723958 (1988-02-01), Pope et al.
patent: 5007790 (1991-04-01), Shell
patent: RE33994 (1992-07-01), Baker et al.
patent: RE34712 (1994-08-01), Boegesoe et al.
patent: 5358970 (1994-10-01), Ruff et al.
patent: 5427798 (1995-06-01), Ludwig et al.
patent: 5472708 (1995-12-01), Chen
patent: 5508040 (1996-04-01), Chen
patent: 5582837 (1996-12-01), Shell
patent: 5656294 (1997-08-01), Friend et al.
patent: 5731000 (1998-03-01), Ruff et al.
patent: 5763493 (1998-06-01), Ruff et al.
patent: 5840329 (1998-11-01), Bai
patent: 5972389 (1999-10-01), Shell et al.
patent: 6096341 (2000-08-01), Seth
patent: 6143327 (2000-11-01), Seth
patent: 6217904 (2001-04-01), Midha et al.
patent: 6342496 (2002-01-01), Jerussi et al.
patent: 6372254 (2002-04-01), Ting et al.
patent: 6500457 (2002-12-01), Midha et al.
patent: 6555136 (2003-04-01), Midha et al.
patent: 6566540 (2003-05-01), Rock et al.
patent: 6627223 (2003-09-01), Percel et al.
patent: 6730321 (2004-05-01), Ting et al.
patent: 6793936 (2004-09-01), Devane et al.
patent: 6905708 (2005-06-01), Li et al.
patent: 2002/0052340 (2002-05-01), Jerussi et al.
patent: 2003/0124196 (2003-07-01), Weinbach et al.
patent: 2003/0133978 (2003-07-01), Davis et al.
patent: 2003/0161874 (2003-08-01), Li et al.
patent: 2004/0028729 (2004-02-01), Shojaei et al.
patent: 2004/0167209 (2004-08-01), Dancer et al.
patent: 2004/0198809 (2004-10-01), Sanchez et al.
patent: 2005/0147678 (2005-07-01), Li et al.
patent: 2005/0196453 (2005-09-01), Jensen et al.
patent: 2005/0197388 (2005-09-01), Jensen et al.
patent: 2006/0058293 (2006-03-01), Weber et al.
patent: WO-96/26718 (1996-09-01), None
patent: WO-98/55107 (1998-12-01), None
patent: WO99/38504 (1999-08-01), None
patent: WO-01/03694 (2001-01-01), None
patent: WO-01/22941 (2001-04-01), None
patent: WO02/10169 (2002-02-01), None
patent: WO-02/087566 (2002-11-01), None
patent: WO-03/000672 (2003-01-01), None
patent: WO-03/006449 (2003-01-01), None
patent: WO-03/011278 (2003-02-01), None
patent: WO-03/051861 (2003-06-01), None
patent: WO-2004/058299 (2004-07-01), None
patent: WO-2004/083197 (2004-09-01), None
Symposia: Escitalopram has potential in anxiety disorder. Inpharma Apr. 26, 2002, ISSN: 1173-8324.
DeVane,J. Clin. Psychiatry2003, 64 (suppl. 18):14-19.
Gerner et al.,Biol. Psychiatry,1998, 43:101S, abstract 336.
Kennedy et al.J. Clin. Psychiatry,2002, 63: 181-186.
Gerner et al,Biol. Psychiatry,1998, 43:99S, abstract 329.
Ashton et al.,J. Clin. Psychiatry,1998, 59(3):112-115.
Gitlin et al.,J. Sex&Marital Therapy2002, 28:131-138.
Sturpe et al.,J. Family PracticeAug. 2002, 51(8):1681.
Fava et al., Psychiatr. Clin. North Am., 1996, 19(2):179-200.
Fava et al., Ann. Clin. Psychiatry, 2003, 15(1): 17-22.
Lam et al., J. Clin. Psychiatry, 2004, 65:337-340.
Trindade et al., Adverse Effects Associated with Selective Serotonin Reuptake Inhibitors and Tricyclic Antidepressants: A Meta-analysis, Canadian Medical Association Journal. Nov. 1998, 159 (10): 1245-1252.
Phillips et al., Depression and Sexual Desire, American Family Physician [online], Aug. 15, 2000, vol. 62, No. 4, retrieved from the internet:<URL: http://www.aafgp.org/afp/20000815/782.html>.
Rampello et al., Dopamine and Depression: Therapeutic Implications CNS Drugs, Jan. 2000, 13(1): 35-45.
International Search Report for PCT/US06/60006, mailed Sep. 25, 2007.
Written Opinion of the International Search Authority for PCT/US06/60006, mailed Sep. 25, 2007.

Affiliated with

Also associated with

Rating

Methods of treating central nervous system disorders with a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating central nervous system disorders with a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating central nervous system disorders with a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4107361